Cargando…
Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019
OBJECTIVES: While the safety of non‐steroidal anti‐inflammatory drugs in COVID‐19 has been questioned, they may be beneficial given the hyper‐inflammatory immune response associated with severe disease. We aimed to assess the safety and potential efficacy of cyclooxygenase‐2 (COX‐2) selective inhibi...
Autores principales: | Ong, Sean Wei Xiang, Tan, Wilnard Yeong Tze, Chan, Yi‐Hao, Fong, Siew‐Wai, Renia, Laurent, Ng, Lisa FP, Leo, Yee‐Sin, Lye, David Chien, Young, Barnaby Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382954/ https://www.ncbi.nlm.nih.gov/pubmed/32728438 http://dx.doi.org/10.1002/cti2.1159 |
Ejemplares similares
-
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021) -
Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection
por: Lee, Pei Hua, et al.
Publicado: (2020) -
Organ‐specific immune response in lethal SARS‐CoV‐2 infection by deep spatial phenotyping
por: Balachander, Akhila, et al.
Publicado: (2022) -
Differentiating coronavirus disease 2019 (COVID-19) from influenza and dengue
por: Thein, Tun-Linn, et al.
Publicado: (2021) -
Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant
por: Lee, Cheryl Yi‐Pin, et al.
Publicado: (2021)